PPARD rs2016522: What Your Genotype Means
The rs2016522 variant is a single nucleotide polymorphism located in the regulatory region of the PPARD gene. It is studied for its potential influence on PPAR-delta expression, which plays a role in lipid metabolism and skeletal muscle endurance adaptations.
What each genotype means
Typical baseline aerobic adaptation
You carry two copies of the major G allele (frequently cataloged on the reverse coding strand as the major T allele, or +294T). This genotype represents the baseline reference profile in athletic studies and is associated with typical skeletal muscle fatty acid oxidation and standard training responses. Available research connecting this non-coding regulatory variant to athletic endurance is limited and heterogeneous across cohorts.
Carried by approximately 60% to 65% of individuals of European ancestry and roughly 45% to 55% of East Asian populations.
Modestly altered metabolic response
You carry one copy of the minor A allele (commonly reported in literature on the reverse coding strand as the C allele, or +294C). In some exercise genomics and candidate gene studies, carrying this allele has been tentatively linked to enhanced lipid utilization and modest differences in endurance capacity, though findings remain mixed. Overall scientific evidence for a direct fitness effect is limited and should not be considered deterministic.
Carried by approximately 30% to 35% of people of European ancestry and up to 40% in some East Asian cohorts.
Atypical muscle metabolic profile
You carry two copies of the minor A allele (also referenced in literature as the CC or +294C homozygote). Several candidate gene association studies suggest this genotype may correlate with differences in PPAR-delta transcriptional activity and skeletal muscle metabolic adaptation during exercise, but evidence is inconsistent and primarily limited to specific athlete cohorts. Lifestyle factors such as structured cardiovascular training and balanced nutrition play a far more dominant role in endurance performance.
Carried by roughly 3% to 5% of individuals of European ancestry and about 8% to 10% of East Asian populations.
Understanding the Variant
The rs2016522 variant is a single nucleotide polymorphism (SNP) situated in the 5' untranslated region (5' UTR) of the PPARD gene. This region is critical because it acts as a regulatory gateway, influencing how the gene is transcribed into messenger RNA (mRNA) and subsequently translated into protein. Because this variant sits in a non-coding regulatory area rather than the protein-coding sequence itself, it does not change the structure of the PPAR-delta protein. Instead, it is hypothesized to alter the efficiency or timing of gene expression. By modulating the levels of PPAR-delta available in cells, this variant may indirectly influence how tissues, particularly skeletal muscle, respond to metabolic demands. Researchers track such variants to understand the genetic architecture behind individual differences in physiological traits, such as how efficiently a person's body utilizes energy during physical activity.
The Role of the PPARD Gene
The PPARD gene encodes the Peroxisome Proliferator-Activated Receptor delta (PPAR-delta) protein, a nuclear receptor that acts as a master regulator of energy metabolism. PPAR-delta is expressed in various tissues, including the liver, adipose tissue, and skeletal muscle. Its primary function is to control the expression of genes involved in fatty acid oxidation and energy uncoupling. In skeletal muscle, PPAR-delta is particularly important for promoting the development of oxidative muscle fibers, which are essential for endurance performance. When activated, PPAR-delta helps the body shift toward burning fat for fuel, which can improve insulin sensitivity and support sustained physical activity. Because of these roles, the PPARD gene is a frequent subject of study in exercise physiology, as variations in its expression levels are thought to contribute to the wide range of human responses to endurance training and metabolic stress.
Research and Evidence Strength
Evidence linking rs2016522 to specific physical or metabolic outcomes is currently considered limited. While the broader PPARD gene is well-documented for its role in metabolism, individual SNPs within the gene often show mixed results across different studies. Some research has suggested that variants in the PPARD regulatory regions may influence athletic performance or the body's response to exercise training, but these findings are not always consistent across diverse populations. For instance, while some studies have identified associations between PPARD variants and endurance capacity, others have found no significant link to metabolic traits like insulin resistance or obesity. Because of these conflicting results, it is important to view this variant as a subject of ongoing scientific inquiry rather than a definitive predictor of physical ability. The complexity of human metabolism means that any single genetic variant likely has only a small, nuanced effect that is heavily modified by environment, diet, and training.
Practical Considerations
It is important to understand that genetic information regarding rs2016522 cannot be used to diagnose health conditions or predict athletic success. The associations observed in scientific literature are statistical trends seen in large groups, not individual guarantees. Factors such as consistent training, nutrition, sleep, and overall lifestyle have a far greater impact on physical fitness and metabolic health than any single SNP. If you are interested in how your genetics might influence your response to exercise or your metabolic profile, this information should be treated as a point of curiosity rather than a medical tool. You should never use genetic data to make decisions about medication, supplements, or drastic changes to your health regimen. Always consult with a qualified healthcare provider or a registered dietitian before making significant changes to your health or fitness plan, as they can provide guidance based on your complete clinical picture.
How common is this variant?
The rs2016522 variant has a minor allele frequency of approximately 0.20 in European populations, meaning it is relatively common across these groups.
Frequently asked questions
Can I use rs2016522 to predict if I will be an elite athlete?
No. Athletic performance is a complex trait influenced by hundreds of genes, as well as years of dedicated training, nutrition, and environmental factors. A single SNP like rs2016522 does not determine athletic potential.
Does this variant affect my risk for type 2 diabetes?
Current research on PPARD variants and diabetes risk is mixed. Some studies have investigated this link, but there is no consensus that rs2016522 is a reliable predictor of diabetes risk in the general population.
Should I change my diet based on my PPARD genotype?
No. You should not alter your diet or exercise routine based on a single genetic variant. Always consult with a healthcare professional or a registered dietitian for personalized nutritional advice.
Where can I find more information about my specific genotype?
You can look up your rsID on public databases like dbSNP or the GWAS Catalog to see the latest research. However, remember that these databases are for scientific reference and are not intended for personal medical interpretation.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2016522?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29